Outcomes and Associated Factors of Discrepant Coronary and Carotid Atherosclerosis

Hyoeun Kim1, Jong-Youn Kim2, Pil-Ki Min2

  • 1Department of Health Promotion, Health Promotion Center, Severance Hospital, Yonsei University Health System.

International Heart Journal
|November 16, 2020
PubMed

Insights

Discrepancies in carotid and coronary artery atherosclerosis are common. Patients with isolated coronary artery disease (CAD) face higher cardiovascular event risks, while isolated carotid plaque increases heart failure and mortality risk.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Significant discrepancies exist between carotid artery atherosclerosis and coronary artery disease (CAD) in some patients.
  • Understanding these discrepancies is crucial for comprehensive cardiovascular risk assessment and management.

Purpose of the Study:

  • To characterize patients with discrepant carotid and coronary atherosclerosis.
  • To evaluate the prognosis of these patients.
  • To identify optimal strategies for detecting pan-vascular atherosclerosis.

Main Methods:

  • Analysis of a database of 5,022 patients undergoing coronary angiography and carotid ultrasonography.
  • Inclusion of clinical data, laboratory tests, echocardiography, and pulse wave velocity (PWV) measurements.
  • Follow-up evaluation of cerebro-cardiovascular (CV) events.

Main Results:

  • 35% of patients showed discrepancies between carotid plaque and CAD.
  • Factors associated with CAD in patients without carotid plaque included male sex, older age, smoking, lower HDL-cholesterol, and lower CCA-EDV.
  • Increased PWV was linked to carotid plaque in patients without CAD.
  • Isolated CAD correlated with higher CV events; isolated carotid plaque correlated with higher heart failure (HF) and mortality.

Conclusions:

  • Coronary evaluation is essential even without carotid plaque in at-risk individuals (older males, smokers, low HDL, low CCA-EDV).
  • Carotid plaque may serve as a risk factor for heart failure.
  • Comprehensive vascular assessment is vital for accurate risk stratification.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
694
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
271
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
492
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
224
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
143
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
203